Company Filing History:

12 out of 614

Mitsubishi Chemical Industries Limited

Mitsubishi Kasei Corporation

patents

Years Active: 1976-1995

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5387609 - Anti-solid tumor agents (1995-02-07),

2. 5300525 - Anti-solid tumor agents (1994-04-05),

3. 5151521 - 1-aminoethyl phosphonic acid derivatives (1992-09-29),

4. 5061806 - Phosphinic acid derivatives (1991-10-29),

5. 5041644 - Peptide derivatives of .beta.-chloro-L(Z)-dehydro-glutamic acid (1991-08-20),

6. 5030732 - Aminoethylphosphinic acid derivatives (1991-07-09),

7. 4963684 - Process for preparing cotarnine (1990-10-16),

8. 4916160 - Anti-tumor promoter agents (1990-04-10),

9. 4769480 - Benzylamine derivative (1988-09-06),

10. 4760145 - Certain 6,7-methylene dioxydihydro or tetrahydro-isoquinoline derivatives (1988-07-26),

11. 4746747 - Anisole derivatives (1988-05-24),

12. 4684732 - Process for preparation of phthalide derivatives (1987-08-04),

13. 4622181 - Process for producing an estrone acetal (1986-11-11),

14. 4440788 - Cysteine derivatives (1984-04-03),

15. 4251442 - Method for synthesis of penicillin (1981-02-17),

Title: Yoshiharu Morita: A Pioneer in Anti-Solid Tumor Agents

Introduction

Yoshiharu Morita, based in Yokohama, Japan, is a distinguished inventor with an impressive portfolio of 20 patents. His work focuses primarily on the development of innovative anti-solid tumor agents that show promise in the fight against cancer. His contributions to the field combine scientific rigor with creative solutions to complex health challenges.

Latest Patents

Morita's latest inventions revolve around anti-solid tumor agents utilizing cembrane-type compounds. These agents are characterized by the general formulas (I) and (II), where R can be a hydrogen atom or an acyl group, serving as effective ingredients in cancer treatment formulations. His research plays a crucial role in enhancing therapeutic options for patients facing solid tumors.

Career Highlights

Throughout his career, Yoshiharu Morita has been associated with leading companies in the chemical and pharmaceutical sectors. Notably, he has worked at Mitsubishi Chemical Industries Limited and Merck & Company, Inc. His experience in these organizations has contributed significantly to his innovation and patent development.

Collaborations

Morita has collaborated with esteemed colleagues in his field, including Tadashi Shirasaka and Junichi Ohya. Their joint efforts have engineered advancements in the development of cancer treatment methodologies, fostering an environment of collaboration and innovation within the industry.

Conclusion

Yoshiharu Morita exemplifies the spirit of innovation that drives progress in the realm of medical research. With his extensive patent portfolio and collaborative spirit, he continues to make significant contributions to the field of oncology, ensuring a brighter future for cancer patients through effective treatment options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.